Literature DB >> 1194853

C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.

M M Hurst, J E Volanakis, R M Stroud, J C Bennett.   

Abstract

A 56 residue fragment derived from a Waldenströme IgM protein and consisting of 24 residues of the amino-terminal portion of the Cmu4 domain disulfide bonded to 32 residues of the carboxy-terminal region of the loop has been shown to fix active C1 (C1) in a C1-fixation assay. Cleavage of the disulfide bond within the CH4 fragment resulted in a marked decrease of C1-fixing ability, although the isolated A and B fragments did retain a limited ability to fix C1. Upon incubation with normal human serum the intact CH4 fragment and equal molar amounts of the isolated A and B peptides consumed C4 suggesting that the C1-activating determinant of IgM remains intact in these three fragments. Furthermore, on a molar basis the intact or the reduced CH4 fragment consumed C4 as effectively as each of its component chains suggesting that transient binding of C1 by the individual A and B peptide chains is sufficient to activate C1. On the basis of these observations it is proposed that a classical complement fixation function, i.e. C1 binding and activation, can be localized within a region of the IgM molecule corresponding to the Cmu4 domain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1194853      PMCID: PMC2189977          DOI: 10.1084/jem.142.5.1322

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization.

Authors:  M W Turner; H Bennich
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

2.  Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin.

Authors:  F W Putnam; G Florent; C Paul; T Shinoda; A Shimizu
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

3.  [The primary structure of a monoclonal IgM-immunoglobulin (macroglobulin Gal.), II: the amino acid sequence of the H-chain (mu-type), subgroup H III. Architecture of the complete IgM-molecule (author's transl)].

Authors:  S Watanabe; H U Barnikol; J Horn; J Bertram; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973 Oct-Nov

Review 4.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

5.  Identity of the Fc fragments of pathological and normal human immunoglobulin M.

Authors:  G Florent; D Lehman; D Lockhart; F W Putnam
Journal:  Biochemistry       Date:  1974-07-30       Impact factor: 3.162

6.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

8.  Evidence for the absence of noncovalent bonds in the Fcmu region of IgM.

Authors:  R B Hester; J E Mole; R E Schrohenloher
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  The structural basis for binding of complement by immunoglobulin M.

Authors:  M M Hurst; J E Volanakis; R B Hester; R M Stroud; J C Bennett
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

  9 in total
  9 in total

1.  Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.

Authors:  G Füst; G A Medgyesi; E Rajnavölgyi; M Csécsi-Nagy; K Czikora; J Gergely
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain.

Authors:  M J Shulman; N Pennell; C Collins; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.

Authors:  M M Hurst; J E Volanakis; R M Stroud; J C Bennett
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

4.  Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

Authors:  G Füst; L Bertók; S Juhász-Nagy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Mutations affecting the structure and function of immunoglobulin M.

Authors:  M J Shulman; C Heusser; C Filkin; G Köhler
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  Factors influencing the in vitro interaction between immunoglobulins and isolated C1: a critical study.

Authors:  G Füst; G A Medgyesi; M Csécsi-Nagy; E Rajnavölgyi; J Gergely
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

7.  Insoluble polyanions as activators of both pathways of complement.

Authors:  R Burger; D Bitter-Suermann; M Loos; U Hadding
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

8.  Amino acid sequence of a mouse immunoglobulin mu chain.

Authors:  M Kehry; C Sibley; J Fuhrman; J Schilling; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

Review 9.  Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?

Authors:  Katelyn Jones; Anca F Savulescu; Frank Brombacher; Sabelo Hadebe
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.